EMMI, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.451
EU - Europa 11.538
AS - Asia 4.633
SA - Sud America 577
OC - Oceania 135
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 2
Totale 32.428
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.374
RU - Federazione Russa 4.451
PL - Polonia 1.905
IT - Italia 1.593
HK - Hong Kong 1.514
SG - Singapore 1.319
IE - Irlanda 1.204
CN - Cina 878
SE - Svezia 778
BR - Brasile 525
DE - Germania 332
FR - Francia 301
IN - India 298
FI - Finlandia 253
JO - Giordania 214
CH - Svizzera 191
GB - Regno Unito 169
AU - Australia 133
ID - Indonesia 124
NL - Olanda 93
VN - Vietnam 73
ES - Italia 69
AT - Austria 59
CA - Canada 47
TR - Turchia 45
UA - Ucraina 41
CI - Costa d'Avorio 40
BE - Belgio 25
BD - Bangladesh 18
SA - Arabia Saudita 18
JP - Giappone 16
CZ - Repubblica Ceca 15
DK - Danimarca 15
ZA - Sudafrica 15
MX - Messico 14
IR - Iran 12
KR - Corea 12
AR - Argentina 11
IL - Israele 11
PE - Perù 11
IQ - Iraq 10
GR - Grecia 9
EG - Egitto 8
MA - Marocco 8
UZ - Uzbekistan 8
CO - Colombia 7
AZ - Azerbaigian 6
KG - Kirghizistan 6
PK - Pakistan 6
RO - Romania 6
VE - Venezuela 6
CL - Cile 5
CR - Costa Rica 5
DZ - Algeria 5
EC - Ecuador 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
AM - Armenia 4
GE - Georgia 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
PA - Panama 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
TN - Tunisia 4
BG - Bulgaria 3
BO - Bolivia 3
LI - Liechtenstein 3
PY - Paraguay 3
SC - Seychelles 3
TW - Taiwan 3
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KH - Cambogia 2
LV - Lettonia 2
MU - Mauritius 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
KY - Cayman, isole 1
LK - Sri Lanka 1
MK - Macedonia 1
NI - Nicaragua 1
QA - Qatar 1
SV - El Salvador 1
Totale 32.426
Salva come PNG Salva come JPEG
Città #
Santa Clara 5.012
Warsaw 1.897
Fairfield 1.509
Hong Kong 1.280
Dublin 1.202
Chandler 850
Ashburn 845
Singapore 807
Woodbridge 647
Seattle 584
Houston 530
Cambridge 509
Wilmington 420
Lawrence 403
Altamura 356
Florence 332
Moscow 309
Princeton 280
Beijing 238
Boston 220
Mumbai 219
Ann Arbor 213
Paris 212
Bern 175
Buffalo 155
Shanghai 134
Melbourne 130
Munich 127
New York 125
Jakarta 123
San Diego 116
Helsinki 100
Medford 98
Boardman 90
Los Angeles 87
Turku 84
Hefei 80
Kent 63
Rome 61
Milan 60
Vienna 57
Dong Ket 56
Falls Church 53
Norwalk 50
São Paulo 48
Barcelona 44
Bengaluru 44
London 42
Abidjan 40
Hillsboro 39
Frankfurt am Main 35
Toronto 31
Redwood City 29
Guangzhou 27
Lappeenranta 27
Yubileyny 27
Brussels 25
Castelliri 23
The Dalles 23
Phoenix 21
Andover 20
Bari 20
Washington 19
Belo Horizonte 18
Genoa 18
West Jordan 16
Jacksonville 15
Chicago 14
Rio de Janeiro 14
Bologna 13
Brooklyn 13
Falkenstein 13
San Francisco 13
Bexley 12
Pune 12
Amman 11
Copenhagen 11
Düsseldorf 11
Kilburn 11
Palermo 11
Seoul 11
Tokyo 11
Dearborn 10
Nuremberg 10
Arezzo 9
Dhaka 9
Lima 9
Naples 9
Napoli 9
Redmond 9
Siena 9
Campi Bisenzio 8
Goiânia 8
Johannesburg 8
Nanjing 8
Padova 8
Uberlândia 8
Amsterdam 7
Atlanta 7
Brasília 7
Totale 21.882
Salva come PNG Salva come JPEG
Nome #
Behçet's syndrome patients exhibit specific microbiome signature. 338
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 292
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 290
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 271
SIRT1 activity is decreased in lesional psoriatic skin 251
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 251
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 237
Digital ulcers secondary to Sneddon's syndrome successfully treated with Bosentan: not only useful in Systemic Sclerosis 227
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 223
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 212
A biochemical approach to detect oxidative stress in infertile women undergoing assisted reproductive technology procedures 205
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 184
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 184
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 183
ANCA-associated vasculitis in childhood: Recent advances 180
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study. 177
Thrombosis in vasculitis: from pathogenesis to treatment 170
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 165
Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: A proof of concept study 161
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 161
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 160
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 159
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 158
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 158
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 155
Response to interleukin-1 inhibitors in 140 Italian patients with adult-onset still's disease: A multicentre retrospective observational study 154
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 154
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 153
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 148
Cardiac involvement in Churg Strauss syndrome: an update on cardiological manifestations 147
Thrombosis in inflammatory bowel diseases: What's the link? 146
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study 145
A large-scale genetic analysis reveals an autoimmune origin of idiopathic retroperitoneal fibrosis 144
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: A multicenter study from the AIDA Network PFAPA syndrome registry 142
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 141
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 140
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 139
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 139
Pathogenesis of Behcet Syndrome 138
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 138
Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report 138
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 138
Intravenous immunoglobulin therapy: a snapshot for the internist. 138
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 137
Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS 135
Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: An uncommon adverse effect? 135
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 135
Brief Report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein purpura) 133
Systemic lupus erythematosus: immunopathogenesis and novel therapeutic targets 132
Lobular panniculitis with small vessel vasculitis associated with ulcerative colitis. 131
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet's phenotype: A multicentre study 130
The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development. 129
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 128
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 128
Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome 128
A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy. 127
Secukinumab reduces plasma oxidative stress in psoriasis: A case-based experience 126
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting 126
A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome 126
Cardiac involvement in eosinophilic granulomatosis with polyangiitis (formerly Churg-Strauss syndrome): Prospective evaluation at a tertiary referral centre 125
Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion 124
Prognostic Value of Degree and Types of Anaemia on Clinical Outcomes for Hospitalised Older Patients 124
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 124
Impact of cardiovascular and immunologic variables on subclinical carotid atherosclerosis in subjects with anti-phospholipid antibodies 124
The "multifaceted" onset of vasculitis neuropathy 124
Significance of PR3-ANCA Positivity in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss) 124
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 123
Infliximab and Cogan's syndrome 123
Sharing data of clinical trials 123
The Presence of Uveitis Is Associated With a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 123
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 123
A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis 122
Pharmacological prevention of venous thromboembolism in orthopaedic surgery 121
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 121
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 121
I farmaci biologici 121
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 120
Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study 119
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 119
MRI evaluation of the "central vein sign" in brain white matter lesions of multiple sclerosis and systemic autoimmune diseases. 119
OP0148 MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A RETROSPECTIVE REAL-WORLD EUROPEAN STUDY ON 142 PATIENTS 119
Rapid desensitization to anakinra-related delayed reaction: Need for a standardized protocol 118
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 118
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study 118
CSF/serum matrix metallopeptidase‐9 ratio discriminates neuro Behçet from multiple sclerosis 118
Clinical and Prognostic Significance of Serum IgG4 in Chronic Periaortitis. An Analysis of 113 Patients 117
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 117
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 117
Pulmonary hemorrhage: not only vasculitis. 114
Anakinra for resistant Behçet uveitis: why not? 114
Reply: anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series 114
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 114
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review 114
Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study 114
Favorable pregnancy outcome in a patient with systemic lupus erythematosus treated with belimumab: A confirmation report 114
Rituximab for chronic periaortitis without evidence of IgG4-related disease: A long-term follow-up study of 20 patients 114
THU0540 Efficacy and safety of adalimumab in behÇet's disease related uveitis: a multicenter retrospective observational study 114
Predictors of Sustained Clinical Response in Patients With Behçet's Disease-Related Uveitis Treated With Infliximab and Adalimumab 114
Susceptibility weighted MRI can help differentiating pathogenesis of white matter lesions in MS and CNS inflammatory vasculopathies. 113
New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy 113
Totale 14.695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020216 0 0 0 0 0 0 0 0 0 0 0 216
2020/20212.768 155 257 102 463 240 211 223 168 307 326 147 169
2021/20221.959 56 75 231 74 50 130 50 215 125 82 281 590
2022/20235.057 450 1.102 267 219 219 871 681 266 496 63 179 244
2023/20242.502 92 172 342 162 162 352 128 481 77 235 154 145
2024/202516.123 598 1.722 896 2.595 4.267 2.016 460 790 831 601 727 620
Totale 32.961